Efficacy and Safety of Statins for Secondary Stroke Prevention in Patients With Cerebral Microbleeds: Jury Is Still Out

Authors

Zurab Nadareishvili, From the Department of Neurology and Rehabilitation Medicine (Z.N.), The George Washington University School of Medicine and Health Sciences, Washington, DC, and Comprehensive Stroke Center, VHC Health, Arlington, VA; and Department of Medicine-Neurology (A.H.K., A.S.), McMaster University / Population Health Research Institute, Hamilton, ON, Canada.
Aristeidis H. Katsanos, From the Department of Neurology and Rehabilitation Medicine (Z.N.), The George Washington University School of Medicine and Health Sciences, Washington, DC, and Comprehensive Stroke Center, VHC Health, Arlington, VA; and Department of Medicine-Neurology (A.H.K., A.S.), McMaster University / Population Health Research Institute, Hamilton, ON, Canada.
Ashkan Shoamanesh, From the Department of Neurology and Rehabilitation Medicine (Z.N.), The George Washington University School of Medicine and Health Sciences, Washington, DC, and Comprehensive Stroke Center, VHC Health, Arlington, VA; and Department of Medicine-Neurology (A.H.K., A.S.), McMaster University / Population Health Research Institute, Hamilton, ON, Canada.

Document Type

Editorial

Publication Date

4-9-2024

Journal

Neurology

Volume

102

Issue

7

DOI

10.1212/WNL.0000000000209261

APA Citation

Nadareishvili, Zurab; Katsanos, Aristeidis H.; and Shoamanesh, Ashkan, "Efficacy and Safety of Statins for Secondary Stroke Prevention in Patients With Cerebral Microbleeds: Jury Is Still Out" (2024). GW Authored Works. Paper 4752.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/4752

Department

Neurology